Cargando…

Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, M, Govindaraj, V, Kottaisamy, R, Vijayarangam, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196285/
https://www.ncbi.nlm.nih.gov/pubmed/35466662
http://dx.doi.org/10.4103/jpgm.JPGM_1226_20
_version_ 1784727152379297792
author Bai, M
Govindaraj, V
Kottaisamy, R
Vijayarangam, N
author_facet Bai, M
Govindaraj, V
Kottaisamy, R
Vijayarangam, N
author_sort Bai, M
collection PubMed
description Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was admitted for left pyopneumothorax. He was started on intravenous piperacillin-tazobactam (Pip/Taz) and clindamycin. After 10 days of treatment, he developed high grade fever with maculopapular rashes with areas of scaling. He had elevated WBC counts with eosinophils of 21% and raised serum transaminases. After excluding other possible etiologies for febrile illness, a possibility of DRESS was considered. Naranjo scale, used for causality assessment, yielded a total score of 6, pointing toward probable adverse drug reaction. Also, the patient had 6 out of the 7 inclusion criteria for DRESS as per European Registry of Severe Cutaneous Adverse Reaction (RegiScar) scoring. Pip/Taz was found to be causative drug and was discontinued. He was conservatively managed with antipyretics and topical steroids. Fever subsided the day after stopping Pip/Taz and his rashes resolved gradually. In conclusion the possibility of antibiotics-induced DRESS should be considered and high index of vigilance is advised.
format Online
Article
Text
id pubmed-9196285
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91962852022-06-15 Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use Bai, M Govindaraj, V Kottaisamy, R Vijayarangam, N J Postgrad Med ADR Report Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, idiosyncratic reaction to a drug which presents after a prolonged latency period. Although it most commonly occurs with aromatic anticonvulsants, antibiotics are also occasionally implicated. A 50-year-old male was admitted for left pyopneumothorax. He was started on intravenous piperacillin-tazobactam (Pip/Taz) and clindamycin. After 10 days of treatment, he developed high grade fever with maculopapular rashes with areas of scaling. He had elevated WBC counts with eosinophils of 21% and raised serum transaminases. After excluding other possible etiologies for febrile illness, a possibility of DRESS was considered. Naranjo scale, used for causality assessment, yielded a total score of 6, pointing toward probable adverse drug reaction. Also, the patient had 6 out of the 7 inclusion criteria for DRESS as per European Registry of Severe Cutaneous Adverse Reaction (RegiScar) scoring. Pip/Taz was found to be causative drug and was discontinued. He was conservatively managed with antipyretics and topical steroids. Fever subsided the day after stopping Pip/Taz and his rashes resolved gradually. In conclusion the possibility of antibiotics-induced DRESS should be considered and high index of vigilance is advised. Wolters Kluwer - Medknow 2022 2022-04-20 /pmc/articles/PMC9196285/ /pubmed/35466662 http://dx.doi.org/10.4103/jpgm.JPGM_1226_20 Text en Copyright: © 2022 Journal of Postgraduate Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle ADR Report
Bai, M
Govindaraj, V
Kottaisamy, R
Vijayarangam, N
Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title_full Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title_fullStr Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title_full_unstemmed Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title_short Drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
title_sort drug reaction with eosinophilia and systemic symptoms syndrome related to piperacillin-tazobactam use
topic ADR Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196285/
https://www.ncbi.nlm.nih.gov/pubmed/35466662
http://dx.doi.org/10.4103/jpgm.JPGM_1226_20
work_keys_str_mv AT baim drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse
AT govindarajv drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse
AT kottaisamyr drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse
AT vijayarangamn drugreactionwitheosinophiliaandsystemicsymptomssyndromerelatedtopiperacillintazobactamuse